Protein Information

Name cyclin dependent kinase (protein family or complex)
Synonyms cyclin dependent kinase; cyclin dependent kinases

Compound Information

Name biphenyl
CAS 1,1′-biphenyl

Reference List

PubMed Abstract RScore(About this table)
19657189 Shin HC, Song DW, Baek WK, Lee SR, Kwon TK, Lee J, Park SH, Jang BC, Park JW: Anticancer activity and differentially expressed genes in head and neck cancer cells treated with a novel cyclin-dependent kinase inhibitor. Chemotherapy. 2009;55(5):353-62. Epub 2009 Aug 5.

In this study, we investigated the antitumor effect and differentially expressed genes (DEGs) in head and neck cancer cells treated by a novel CDK inhibitor, 2-[1,1'-biphenyl]- 4-yl-N-[5-(1,1-dioxo-1lambda (6)-isothiazolidin-2-yl)-1H-indazol-3-yl] acetamide (BAI).
2(0,0,0,2) Details
18468578 Lee SJ, Cho YH, Park K, Kim EJ, Jung KH, Park SS, Kim WJ, Moon SK: Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Biochem Pharmacol. 2008 Jun 15;75(12):2289-300. Epub 2008 Apr 8.


In addition, magnolol treatment strongly induced p27KIP1 expression, and down-regulated expression of cyclin-dependent kinases (CDKs) and cyclins.
1(0,0,0,1) Details
20156602 Oh JH, Park EJ, Park JW, Lee J, Lee SH, Kwon TK: A novel cyclin-dependent kinase inhibitor down-regulates tumor necrosis factor-alpha (TNF-alpha)-induced expression of cell adhesion molecules by inhibition of NF-kappaB activation in human pulmonary epithelial cells. Int Immunopharmacol. 2010 Feb 13.

BAI (a novel cyclin-dependent kinase (CDK) inhibitor, 2-[1,1'-biphenyl]-4-yl-N-[5-(1,1-dioxo-1lambda (6)-isothiazolidin-2-yl)-1H- indazol-3-yl] acetamide) is known to have anti-proliferative activity, but the mechanism responsible for it remains unclear.
32(0,1,1,2) Details